IDYA Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-02-24 | Stone Paul A. | officer: Chief Financial Officer | 140,000 | A-Award | A | 140,000 | 17.04 | 2,385,600.00 |
| 2023-02-24 | Hata Yujiro S | director, officer: President and CEO | 400,000 | A-Award | A | 400,000 | 17.04 | 6,816,000.00 |
| 2023-02-24 | Beaupre Darrin | officer: Chief Medical Officer | 90,000 | A-Award | A | 90,000 | 17.04 | 1,533,600.00 |
| 2023-02-24 | WHITE MICHAEL ANTHONY | officer: Chief Scientific Officer | 165,000 | A-Award | A | 165,000 | 17.04 | 2,811,600.00 |
| 2023-02-24 | Throne Jason | officer: Chief Legal Officer | 100,000 | A-Award | A | 100,000 | 17.04 | 1,704,000.00 |
| 2022-06-09 | Kelley Susan L. | director | 11,000 | A-Award | A | 11,000 | 12.29 | 135,190.00 |
| 2022-06-09 | YARNO WENDY L | director | 11,000 | A-Award | A | 11,000 | 12.29 | 135,190.00 |
| 2022-06-09 | SHANNON TIMOTHY M | director | 11,000 | A-Award | A | 11,000 | 12.29 | 135,190.00 |
| 2022-06-09 | ROSEN TERRY J | director | 11,000 | A-Award | A | 11,000 | 12.29 | 135,190.00 |
| 2022-06-09 | Morrison Scott W | director | 11,000 | A-Award | A | 11,000 | 12.29 | 135,190.00 |
| 2022-06-09 | Hampton Malcolm Garret | director | 11,000 | A-Award | A | 11,000 | 12.29 | 135,190.00 |
| 2022-06-09 | Stein Jeffrey | director | 11,000 | A-Award | A | 11,000 | 12.29 | 135,190.00 |
| 2022-04-05 | MACKEY CATHERINE J | director | 22,000 | A-Award | A | 22,000 | 11.80 | 259,600.00 |
| 2022-03-01 | Hata Yujiro S | director, officer: President and CEO | 260,000 | A-Award | A | 260,000 | 12.86 | 3,343,600.00 |
| 2022-03-01 | WHITE MICHAEL ANTHONY | officer: SVP, Chief Scientific Officer | 92,500 | A-Award | A | 92,500 | 12.86 | 1,189,550.00 |
| 2022-03-01 | Stone Paul A. | officer: SVP, Chief Financial Officer | 92,500 | A-Award | A | 92,500 | 12.86 | 1,189,550.00 |
| 2022-03-01 | Throne Jason | officer: SVP, General Counsel | 63,750 | A-Award | D | 63,750 | 12.86 | 819,825.00 |
| 2021-10-25 | WHITE MICHAEL ANTHONY | officer: SVP, Chief Scientific Officer | 200,000 | A-Award | A | 200,000 | 22.01 | 4,402,000.00 |
| 2021-10-04 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 23,437 | M-Exempt | D | 1,500 | 11.08 | 16,620.00 |
| 2021-10-04 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 78,789 | S-Sale | D | 1,000 | 26.62 | 26,621.00 |
| 2021-10-04 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 79,789 | S-Sale | D | 500 | 25.85 | 12,924.00 |
| 2021-10-04 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 80,289 | M-Exempt | A | 1,500 | 11.08 | 16,620.00 |
| 2021-09-08 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 78,789 | S-Sale | D | 200 | 27.67 | 5,534.00 |
| 2021-09-08 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 85,860 | M-Exempt | A | 7,071 | 4.31 | 30,476.01 |
| 2021-09-08 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 90,173 | M-Exempt | A | 4,313 | 11.08 | 47,788.04 |
| 2021-09-08 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 78,989 | S-Sale | D | 11,184 | 27.41 | 306,559.03 |
| 2021-09-08 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 59,048 | M-Exempt | D | 7,071 | 4.31 | 30,476.01 |
| 2021-09-08 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 24,937 | M-Exempt | D | 4,313 | 11.08 | 47,788.04 |
| 2021-09-07 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 78,905 | M-Exempt | A | 116 | 4.31 | 499.96 |
| 2021-09-07 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 78,789 | S-Sale | D | 116 | 4.31 | 499.96 |
| 2021-09-07 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 66,119 | M-Exempt | D | 116 | 4.31 | 499.96 |
| 2021-09-07 | Stone Paul A. | officer: SVP, Chief Financial Officer | 12,944 | S-Sale | D | 2,500 | 27.42 | 68,542.50 |
| 2021-09-02 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 78,789 | S-Sale | D | 10,000 | 25.09 | 250,943.00 |
| 2021-08-09 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 89,189 | S-Sale | D | 11,100 | 22.96 | 254,862.66 |
| 2021-08-09 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 88,789 | S-Sale | D | 400 | 23.52 | 9,406.00 |
| 2021-08-09 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 66,235 | M-Exempt | D | 1,500 | 4.31 | 6,465.00 |
| 2021-08-09 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 100,289 | M-Exempt | A | 1,500 | 4.31 | 6,465.00 |
| 2021-07-27 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 67,735 | M-Exempt | D | 5,000 | 6.92 | 34,600.00 |
| 2021-07-27 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 98,789 | S-Sale | D | 10,000 | 25.15 | 251,460.00 |
| 2021-07-27 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 39,500 | M-Exempt | D | 5,000 | 6.92 | 34,600.00 |
| 2021-07-27 | Throne Jason | officer: SVP, General Counsel | 62,610 | M-Exempt | D | 10,000 | 13.34 | 133,400.00 |
| 2021-07-27 | Throne Jason | officer: SVP, General Counsel | 10,000 | M-Exempt | A | 10,000 | 13.34 | 133,400.00 |
| 2021-07-27 | Throne Jason | officer: SVP, General Counsel | 0 | S-Sale | D | 10,000 | 13.34 | 133,400.00 |
| 2021-07-27 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 103,789 | M-Exempt | A | 5,000 | 6.92 | 34,600.00 |
| 2021-07-27 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 108,789 | M-Exempt | A | 5,000 | 6.92 | 34,600.00 |
| 2021-07-06 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 100,289 | M-Exempt | A | 1,500 | 6.92 | 10,380.00 |
| 2021-07-06 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 98,889 | S-Sale | D | 1,400 | 22.20 | 31,081.96 |
| 2021-07-06 | Throne Jason | officer: SVP, General Counsel | 0 | S-Sale | D | 359 | 22.68 | 8,140.43 |
| 2021-07-06 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 98,789 | S-Sale | D | 100 | 22.76 | 2,276.00 |
| 2021-07-06 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 44,500 | M-Exempt | D | 1,500 | 6.92 | 10,380.00 |
| 2021-07-06 | Throne Jason | officer: SVP, General Counsel | 2,390 | S-Sale | D | 1,142 | 22.68 | 25,895.19 |
| 2021-07-06 | Throne Jason | officer: SVP, General Counsel | 10,000 | M-Exempt | A | 2,390 | 13.34 | 31,882.60 |
| 2021-07-06 | Throne Jason | officer: SVP, General Counsel | 3,532 | S-Sale | D | 6,468 | 22.16 | 143,357.40 |
| 2021-07-06 | Throne Jason | officer: SVP, General Counsel | 67,390 | M-Exempt | D | 7,610 | 7.01 | 53,346.10 |
| 2021-07-06 | Throne Jason | officer: SVP, General Counsel | 7,610 | M-Exempt | A | 7,610 | 7.01 | 53,346.10 |
| 2021-07-06 | Throne Jason | officer: SVP, General Counsel | 359 | S-Sale | D | 2,031 | 22.16 | 45,015.29 |
| 2021-07-06 | Throne Jason | officer: SVP, General Counsel | 72,610 | M-Exempt | D | 2,390 | 13.34 | 31,882.60 |
| 2021-06-17 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 46,000 | M-Exempt | D | 3,893 | 22.49 | 87,539.94 |
| 2021-06-17 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 102,682 | M-Exempt | A | 3,893 | 22.49 | 87,539.94 |
| 2021-06-17 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 98,789 | S-Sale | D | 3,893 | 22.49 | 87,539.94 |
| 2021-06-16 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 99,896 | M-Exempt | A | 1,107 | 6.92 | 7,660.44 |
| 2021-06-16 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 98,789 | S-Sale | D | 1,107 | 6.92 | 7,660.44 |
| 2021-06-16 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 49,893 | M-Exempt | D | 1,107 | 6.92 | 7,660.44 |
| 2021-06-10 | Stein Jeffrey | director | 11,000 | A-Award | A | 11,000 | 21.66 | 238,260.00 |
| 2021-06-10 | YARNO WENDY L | director | 11,000 | A-Award | A | 11,000 | 21.66 | 238,260.00 |
| 2021-06-10 | Morrison Scott W | director | 11,000 | A-Award | A | 11,000 | 21.66 | 238,260.00 |
| 2021-06-10 | Hampton Malcolm Garret | director | 11,000 | A-Award | A | 11,000 | 21.66 | 238,260.00 |
| 2021-06-10 | ROSEN TERRY J | director | 11,000 | A-Award | A | 11,000 | 21.66 | 238,260.00 |
| 2021-06-10 | SHANNON TIMOTHY M | director | 11,000 | A-Award | A | 11,000 | 0.00 | 0.00 |
| 2021-06-07 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 100,289 | M-Exempt | A | 1,500 | 6.92 | 10,380.00 |
| 2021-06-07 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 98,789 | S-Sale | D | 1,500 | 6.92 | 10,380.00 |
| 2021-06-07 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 51,000 | M-Exempt | D | 1,500 | 6.92 | 10,380.00 |
| 2021-05-28 | Stone Paul A. | officer: SVP, Chief Financial Officer | 13,803 | A-Award | A | 859 | 11.36 | 9,762.11 |
| 2021-05-11 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 103,789 | M-Exempt | A | 5,000 | 6.92 | 34,600.00 |
| 2021-05-11 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 98,789 | S-Sale | D | 5,000 | 6.92 | 34,600.00 |
| 2021-05-11 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 52,500 | M-Exempt | D | 5,000 | 6.92 | 34,600.00 |
| 2021-02-24 | Lackner Mark | officer: SVP, Head of Biology | 45,000 | A-Award | A | 45,000 | 19.52 | 878,400.00 |
| 2021-02-24 | Throne Jason | officer: SVP, General Counsel | 52,500 | A-Award | A | 52,500 | 19.52 | 1,024,800.00 |
| 2021-02-24 | Hata Yujiro S | director, officer: President and CEO | 195,000 | A-Award | A | 195,000 | 19.52 | 3,806,400.00 |
| 2021-02-24 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 80,000 | A-Award | A | 80,000 | 19.52 | 1,561,600.00 |
| 2021-02-24 | Stone Paul A. | officer: SVP, Chief Financial Officer | 80,000 | A-Award | A | 80,000 | 19.52 | 1,561,600.00 |
| 2021-02-12 | Kelley Susan L. | director | 22,000 | A-Award | A | 22,000 | 18.91 | 416,020.00 |
| 2021-02-10 | Lackner Mark | officer: SVP, Head of Biology | 596 | M-Exempt | A | 596 | 21.00 | 12,516.00 |
| 2021-02-10 | Lackner Mark | officer: SVP, Head of Biology | 0 | S-Sale | D | 596 | 21.00 | 12,516.00 |
| 2021-02-10 | Lackner Mark | officer: SVP, Head of Biology | 33,014 | M-Exempt | D | 596 | 21.00 | 12,516.00 |
| 2021-02-09 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 103,789 | M-Exempt | A | 5,000 | 6.92 | 34,600.00 |
| 2021-02-09 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 98,789 | S-Sale | D | 5,000 | 6.92 | 34,600.00 |
| 2021-02-09 | Dillon Michael P. | officer: SVP, Chief Scientific Officer | 57,500 | M-Exempt | D | 5,000 | 6.92 | 34,600.00 |
| 2021-02-09 | Lackner Mark | officer: SVP, Head of Biology | 1,104 | M-Exempt | A | 1,104 | 21.05 | 23,234.34 |
| 2021-02-09 | Lackner Mark | officer: SVP, Head of Biology | 0 | S-Sale | D | 1,104 | 21.05 | 23,234.34 |
| 2021-02-09 | Lackner Mark | officer: SVP, Head of Biology | 33,610 | M-Exempt | D | 1,104 | 21.05 | 23,234.34 |
| 2021-02-08 | Lackner Mark | officer: SVP, Head of Biology | 300 | M-Exempt | A | 300 | 6.98 | 2,094.00 |
| 2021-02-08 | Lackner Mark | officer: SVP, Head of Biology | 34,714 | M-Exempt | D | 300 | 6.98 | 2,094.00 |
| 2021-02-08 | Lackner Mark | officer: SVP, Head of Biology | 200 | S-Sale | D | 100 | 21.02 | 2,102.00 |
| 2021-02-08 | Lackner Mark | officer: SVP, Head of Biology | 0 | S-Sale | D | 200 | 21.00 | 4,200.00 |
| 2021-02-02 | BVF PARTNERS L P/IL | other: See Explanation of Responses | 1,188,131 | S-Sale | D | 16,850 | 18.00 | 303,300.00 |
| 2021-02-02 | BVF PARTNERS L P/IL | other: See Explanation of Responses | 233,150 | S-Sale | D | 4,325 | 18.00 | 77,850.00 |
| 2021-02-02 | BVF PARTNERS L P/IL | other: See Explanation of Responses | 1,642,186 | S-Sale | D | 25,234 | 18.00 | 454,212.00 |
| 2021-01-26 | Lackner Mark | officer: SVP, Head of Biology | 800 | S-Sale | D | 1,701 | 18.30 | 31,124.39 |
| 2021-01-26 | Lackner Mark | officer: SVP, Head of Biology | 1,378 | M-Exempt | A | 377 | 4.62 | 1,741.74 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.